- Home
- NSIT vs RXRX Comparison
NSIT vs RXRX Comparison
Compare NSIT & RXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NSIT | RXRX |
|---|---|---|
| Founded | 1988 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.4B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | NSIT | RXRX |
|---|---|---|
| Price | $82.94 | $3.28 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 5 |
| Target Price | ★ $118.75 | $7.20 |
| AVG Volume (30 Days) | 327.7K | ★ 14.3M |
| Earning Date | 05-07-2026 | 06-01-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 14.79 |
| EPS | ★ 4.86 | N/A |
| Revenue | ★ $8,247,180,000.00 | $74,681,000.00 |
| Revenue This Year | $3.79 | $16.50 |
| Revenue Next Year | $2.16 | $66.44 |
| P/E Ratio | $17.06 | ★ N/A |
| Revenue Growth | N/A | ★ 26.92 |
| 52 Week Low | $77.10 | $2.98 |
| 52 Week High | $160.68 | $7.18 |
Technical Indicators
Market Signals| Indicator | NSIT | RXRX |
|---|---|---|
| Relative Strength Index (RSI) | 47.05 | 35.88 |
| Support Level | $79.24 | $2.98 |
| Resistance Level | $88.04 | $5.12 |
| Average True Range (ATR) | 2.98 | 0.20 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 32.87 | 2.41 |
Price Performance
Historical ComparisonAbout NSIT Insight Enterprises Inc.
Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, government agencies, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital workplace, cloud/data center transformation, IT modernization, Cyber Security and supply chain optimization solutions and services.
About RXRX Recursion Pharmaceuticals Inc.
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.